SFM
IBB icon

Soros Fund Management’s iShares Biotechnology ETF IBB Stock Holding History

Soros Fund Management’s Portfolio IBB Stock Details IBB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-450,000
Closed -$41M – 230
2014
Q3 		$41M Buy
+450,000
New +$39.5M 0.31% 79

Other funds holding IBB

Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
CB
Commerce Bank Kansas City, Missouri $22.8B AUM 28.56% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Soros Fund Management's IBB Position: Q3 2023 in Review

Soros Fund Management sold out of iShares Biotechnology ETF (IBB) in Q3 2023, closing a stake of 15,800 shares — an estimated $2.01M sold.

Soros Fund Management first reported a position in IBB in Q2 2015 and held it in 8 quarters. The position peaked at $17.6M in Q1 2016. 833 funds tracked by Wall St. Rank hold IBB as of Q3 2023.

  • Soros Fund Management reported no remaining iShares Biotechnology ETF position as of Q3 2023 after selling out during the quarter.
  • Soros Fund Management sold 15,800 iShares Biotechnology ETF shares in Q3 2023, an estimated $2.01M.
  • Soros Fund Management first reported a position in iShares Biotechnology ETF in Q2 2015 and held it in 8 quarters.
  • Soros Fund Management's iShares Biotechnology ETF position peaked at $17.6M in Q1 2016.
  • 833 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q3 2023.

Based on Soros Fund Management's 13F filing for Q3 2023, filed 14 Nov 2023.